Nihon Kohden Corporation (NHNKY)
USD 14.63
(0.0%)
USD 14.63
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 17.02 Billion JPY | -0.49% |
| 2023 | 17.11 Billion JPY | -26.99% |
| 2022 | 23.43 Billion JPY | 28.46% |
| 2021 | 18.24 Billion JPY | 85.13% |
| 2020 | 9.85 Billion JPY | -11.95% |
| 2019 | 11.19 Billion JPY | 22.25% |
| 2018 | 9.15 Billion JPY | 0.05% |
| 2017 | 9.14 Billion JPY | -13.0% |
| 2016 | 10.51 Billion JPY | -5.62% |
| 2015 | 11.14 Billion JPY | -9.75% |
| 2014 | 12.34 Billion JPY | 34.91% |
| 2013 | 9.15 Billion JPY | 20.08% |
| 2012 | 7.62 Billion JPY | 15.94% |
| 2011 | 6.57 Billion JPY | 11.09% |
| 2010 | 5.91 Billion JPY | 28.35% |
| 2009 | 4.61 Billion JPY | -18.13% |
| 2008 | 5.63 Billion JPY | 11.46% |
| 2007 | 5.05 Billion JPY | -12.72% |
| 2006 | 5.78 Billion JPY | -11.8% |
| 2005 | 6.56 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 4.21 Billion JPY | 11.17% |
| 2024 Q3 | -71 Million JPY | -101.69% |
| 2024 Q4 | 9.1 Billion JPY | 12916.9% |
| 2024 FY | 17.02 Billion JPY | -0.49% |
| 2024 Q1 | 3.78 Billion JPY | -54.1% |
| 2023 Q4 | 8.25 Billion JPY | 2486.21% |
| 2023 Q3 | 319 Million JPY | -93.44% |
| 2023 Q1 | 3.67 Billion JPY | -43.61% |
| 2023 Q2 | 4.86 Billion JPY | 32.16% |
| 2023 FY | 17.11 Billion JPY | -26.99% |
| 2022 FY | 23.43 Billion JPY | 28.46% |
| 2022 Q1 | 4.53 Billion JPY | -51.53% |
| 2022 Q2 | 7.75 Billion JPY | 70.97% |
| 2022 Q3 | 4.61 Billion JPY | -40.48% |
| 2022 Q4 | 6.52 Billion JPY | 41.3% |
| 2021 FY | 18.24 Billion JPY | 85.13% |
| 2021 Q1 | 1.06 Billion JPY | -78.89% |
| 2021 Q2 | 4.76 Billion JPY | 349.62% |
| 2021 Q4 | 9.36 Billion JPY | 206.32% |
| 2021 Q3 | 3.05 Billion JPY | -35.88% |
| 2020 Q4 | 5.02 Billion JPY | 464.9% |
| 2020 Q1 | -499 Million JPY | -108.04% |
| 2020 Q2 | 4.44 Billion JPY | 990.18% |
| 2020 Q3 | 889 Million JPY | -79.99% |
| 2020 FY | 9.85 Billion JPY | -11.95% |
| 2019 Q3 | 1.07 Billion JPY | -68.32% |
| 2019 FY | 11.19 Billion JPY | 22.25% |
| 2019 Q1 | 538 Million JPY | -89.0% |
| 2019 Q2 | 3.37 Billion JPY | 527.88% |
| 2019 Q4 | 6.2 Billion JPY | 479.91% |
| 2018 Q1 | 16 Million JPY | -99.7% |
| 2018 Q4 | 4.89 Billion JPY | 184.25% |
| 2018 FY | 9.15 Billion JPY | 0.05% |
| 2018 Q3 | 1.72 Billion JPY | -31.84% |
| 2018 Q2 | 2.52 Billion JPY | 15681.25% |
| 2017 Q3 | 2.14 Billion JPY | -22.64% |
| 2017 Q2 | 2.76 Billion JPY | 354.97% |
| 2017 Q1 | -1.08 Billion JPY | -118.51% |
| 2017 FY | 9.14 Billion JPY | -13.0% |
| 2017 Q4 | 5.32 Billion JPY | 148.55% |
| 2016 Q1 | 239 Million JPY | -94.61% |
| 2016 Q3 | 2.13 Billion JPY | -6.28% |
| 2016 Q4 | 5.86 Billion JPY | 174.88% |
| 2016 FY | 10.51 Billion JPY | -5.62% |
| 2016 Q2 | 2.27 Billion JPY | 852.72% |
| 2015 Q1 | 539 Million JPY | -91.38% |
| 2015 FY | 11.14 Billion JPY | -9.75% |
| 2015 Q4 | 4.43 Billion JPY | 71.32% |
| 2015 Q3 | 2.58 Billion JPY | -27.82% |
| 2015 Q2 | 3.58 Billion JPY | 564.94% |
| 2014 Q4 | 6.25 Billion JPY | 137.59% |
| 2014 FY | 12.34 Billion JPY | 34.91% |
| 2014 Q1 | 1.31 Billion JPY | -67.05% |
| 2014 Q2 | 2.14 Billion JPY | 63.22% |
| 2014 Q3 | 2.63 Billion JPY | 22.49% |
| 2013 Q4 | 3.99 Billion JPY | 97.43% |
| 2013 FY | 9.15 Billion JPY | 20.08% |
| 2013 Q1 | 1.06 Billion JPY | -73.8% |
| 2013 Q2 | 2.07 Billion JPY | 95.66% |
| 2013 Q3 | 2.02 Billion JPY | -2.46% |
| 2012 Q3 | 1.26 Billion JPY | -24.18% |
| 2012 Q4 | 4.04 Billion JPY | 219.34% |
| 2012 Q2 | 1.67 Billion JPY | 162.32% |
| 2012 Q1 | 637 Million JPY | -76.9% |
| 2012 FY | 7.62 Billion JPY | 15.94% |
| 2011 FY | 6.57 Billion JPY | 11.09% |
| 2011 Q1 | 450 Million JPY | -78.39% |
| 2011 Q2 | 2.15 Billion JPY | 379.56% |
| 2011 Q3 | 1.2 Billion JPY | -44.07% |
| 2011 Q4 | 2.75 Billion JPY | 128.42% |
| 2010 Q2 | 2.15 Billion JPY | 2122.68% |
| 2010 Q1 | 97 Million JPY | -94.89% |
| 2010 FY | 5.91 Billion JPY | 28.35% |
| 2010 Q4 | 2.08 Billion JPY | 31.61% |
| 2010 Q3 | 1.58 Billion JPY | -26.62% |
| 2009 FY | 4.61 Billion JPY | -18.13% |
| 2009 Q3 | 504 Million JPY | -49.75% |
| 2009 Q4 | 1.9 Billion JPY | 276.98% |
| 2009 Q2 | 1 Billion JPY | 0.0% |
| 2008 FY | 5.63 Billion JPY | 11.46% |
| 2007 FY | 5.05 Billion JPY | -12.72% |
| 2006 FY | 5.78 Billion JPY | -11.8% |
| 2005 FY | 6.56 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AVITA Medical, Inc. | -39.16 Million USD | 43568.917% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 1461559.227% |
| Össur hf. | 58.38 Million USD | -29059.602% |
| QHSLab, Inc. | -468.36 Thousand USD | 3635322.328% |
| Wellstar International, Inc. | -3.1 Million USD | 547829.621% |
| Össur hf. | 58.38 Million USD | -29059.602% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | -125.26 Thousand USD | 13592519.029% |
| Aurora Spine Corporation | -1.68 Million USD | 1013212.868% |
| BrainsWay Ltd. | -4.19 Million USD | 405770.717% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | -722.81 Thousand USD | 2355622.598% |
| Hamilton Thorne Ltd. | -607.02 Thousand USD | 2804940.681% |
| Vivos Inc. | -2.89 Million USD | 588267.626% |
| Kelyniam Global, Inc. | -218.47 Thousand USD | 7793354.025% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 957780.059% |
| Zecotek Photonics Inc. | -3.51 Million USD | 483933.246% |
| Avitar, Inc. | -2.25 Million USD | 753586.524% |
| Nanomix Corporation | -12.33 Million USD | 138152.648% |
| EKF Diagnostics Holdings plc | 2.35 Million USD | -723794.558% |
| Theraclion SA | -3.67 Million USD | 463391.887% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | -1.63 Million USD | 1039092.423% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | -2.64 Million USD | 644720.001% |
| Lombard Medical, Inc. | -31.03 Million USD | 54960.641% |
| ALR Technologies Inc. | -11.89 Million USD | 143215.775% |
| Stratec SE | 14.42 Million USD | -117923.66% |
| Vycor Medical, Inc. | -69.69 Thousand USD | 24430801.238% |
| Heart Tronics, Inc. | -13.32 Million USD | 127854.131% |
| MicroPort Scientific Corporation | -477.62 Million USD | 3664.691% |
| VMS Rehab Systems, Inc. | 46.44 USD | -36662359934.453% |
| NewCardio, Inc. | -11.49 Million USD | 148200.377% |
| Guided Therapeutics, Inc. | -3.48 Million USD | 488090.828% |
| Ingen Technologies, Inc. | -5.06 Million USD | 336483.692% |
| Odyssey Group International, Inc. | -905.77 Thousand USD | 1879824.566% |
| CYduct Diagnostics, Inc. | -418.03 Thousand USD | 4072984.198% |
| Wellness Center USA, Inc. | -752.98 Thousand USD | 2261246.032% |
| SANUWAVE Health, Inc. | -25.8 Million USD | 66074.348% |
| IR-Med Inc. | -4.9 Million USD | 346932.349% |
| Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 121402.417% |
| Polarean Imaging plc | -11.88 Million USD | 143358.58% |
| United American Healthcare Corporation | 723 Thousand USD | -2354810.097% |
| ECGI Holdings, Inc. | -3.61 Million USD | 471617.58% |
| Nu-Med Plus, Inc. | -125.52 Thousand USD | 13563823.85% |
| Capital Group Holdings, Inc. | -658.02 Thousand USD | 2587543.619% |
| ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | 2375210.03% |
| Medical Supply International USA, Inc. | 394.84 Thousand USD | -4312026.431% |
| Urologix, Inc. | -7.6 Million USD | 223890.747% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | 1005294.232% |
| Nexeon MedSystems Inc. | -2.17 Million USD | 781955.228% |
| SS Innovations International, Inc. | -20.94 Million USD | 81400.844% |
| Qualis Innovations, Inc. | -805.02 Thousand USD | 2115075.883% |
| Smith & Nephew plc | 263 Million USD | -6373.764% |
| NIOX Group Plc | 13.64 Million USD | -124719.682% |
| Fuse Medical, Inc. | 1.45 Million USD | -1166093.139% |
| Broncus Holding Corporation | -28.09 Million USD | 60710.16% |
| Brain Scientific Inc. | -12.34 Million USD | 138030.945% |
| Pressure BioSciences, Inc. | -29.31 Million USD | 58180.872% |
| Health Logic Interactive Inc. | -160.24 Thousand USD | 10624881.589% |